ResearcherNanjing Drum Tower HospitalNo recent work listed
Qingshan Pei
Matched on ORCID iD 0000-0002-7447-3869; OpenAlex author ID A5018015311.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2014: 1 paper · 2015: 1 paper
Papers 2
- Gemcitabine sensitizes pancreatic cancer cells to the CTLs antitumor response induced by BCG-stimulated dendritic cells via a Fas-dependent pathway. First author DOI 10.1016/j.pan.2015.04.001↗
- Gemcitabine-treated pancreatic cancer cell medium induces the specific CTL antitumor activity by stimulating the maturation of dendritic cells. First author DOI 10.1016/j.intimp.2013.12.022↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Ying Lv · 2 shared papers, 2014–2015
- Paper Gemcitabine sensitizes pancreatic cancer cells to the CTLs antitumor response induced by BCG-stimulated dendritic cells… DOI 10.1016/j.pan.2015.04.001↗
- Paper Gemcitabine-treated pancreatic cancer cell medium induces the specific CTL antitumor activity by stimulating the matura… DOI 10.1016/j.intimp.2013.12.022↗
- Xiaoping Zou · 2 shared papers, 2014–2015
- Paper Gemcitabine sensitizes pancreatic cancer cells to the CTLs antitumor response induced by BCG-stimulated dendritic cells… DOI 10.1016/j.pan.2015.04.001↗
- Paper Gemcitabine-treated pancreatic cancer cell medium induces the specific CTL antitumor activity by stimulating the matura… DOI 10.1016/j.intimp.2013.12.022↗
- Hesheng Luo · 1 shared paper, 2014
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.